이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

SonoScape Medical 관리

관리 기준 확인 1/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Kunxiang Wu

최고 경영자

CN¥900.0k

총 보상

CEO 급여 비율	n/a
CEO 임기	no data
CEO 소유권	n/a
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	데이터 없음

최근 관리 업데이트

Recent updates

An Intrinsic Calculation For SonoScape Medical Corp. (SZSE:300633) Suggests It's 41% Undervalued

Feb 28

CEO

Kunxiang Wu (61 yo)

no data

테뉴어

CN¥900,000

보상

Mr. Kunxiang Wu is General Manager & Director of SonoScape Medical Corp.

SonoScape Medical 관리

관리 기준 확인 1/4

주요 정보

최근 관리 업데이트

SonoScape Medical Corp., Annual General Meeting, May 10, 2024

SonoScape Medical Corp., Annual General Meeting, May 10, 2024

Less than half of directors are independent

SonoScape Medical Corp. Approves Board Elections

Insufficient new directors

SonoScape Medical Corp. Announces Executive Election

Recent updates

Investor sentiment deteriorates as stock falls 15%

SonoScape Medical Corp. to Report First Half, 2024 Results on Aug 29, 2024

Does SonoScape Medical (SZSE:300633) Have A Healthy Balance Sheet?

Dividend increased to CN¥0.32

SonoScape Medical Corp. 2023 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 29 May 2024

Pinning Down SonoScape Medical Corp.'s (SZSE:300633) P/E Is Difficult Right Now

First quarter 2024 earnings: EPS in line with expectations, revenues disappoint

Price target decreased by 7.8% to CN¥50.15

Full year 2023 earnings: EPS misses analyst expectations

SonoScape Medical Corp., Annual General Meeting, May 10, 2024

SonoScape Medical Corp., Annual General Meeting, May 10, 2024

SonoScape Medical Corp. to Report Q1, 2024 Results on Apr 27, 2024

We Think SonoScape Medical (SZSE:300633) Can Manage Its Debt With Ease

An Intrinsic Calculation For SonoScape Medical Corp. (SZSE:300633) Suggests It's 41% Undervalued

Less than half of directors are independent

Investor sentiment improves as stock rises 17%

SonoScape Medical Corp. Approves Board Elections

SonoScape Medical Corp. to Report Fiscal Year 2023 Results on Apr 12, 2024

Price target decreased by 8.0% to CN¥57.34

Now 21% undervalued

SonoScape Medical Corp. (SZSE:300633) announces an Equity Buyback for CNY 120 million worth of its shares.

SonoScape Medical Corp. (SZSE:300633) announces an Equity Buyback for CNY 120 million worth of its shares.

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Price target decreased by 7.4% to CN¥62.43

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

SonoScape Medical Corp. to Report Q2, 2023 Results on Aug 23, 2023

SonoScape Medical Corp. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date: 08 June 2023

Full year 2022 earnings: EPS exceeds analyst expectations

Investor sentiment improved over the past week

Price target increased to CN¥71.16

Insufficient new directors

Third quarter 2022 earnings released: EPS: CN¥0.17 (vs CN¥0.076 in 3Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.29 (vs CN¥0.18 in 2Q 2021)

Investor sentiment improved over the past week

Sonoscape Medical Corp. Announces Final Dividend on Share A for 2021, Payable on July 15, 2022

SonoScape Medical Corp. Approves 2021 Profit Distribution Plan

SonoScape Medical Corp. Proposes Final Cash Dividend for 2021

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

SonoScape S-Fetus 4.0 Release to Simplify Sonography Process

SonoScape Medical Corp. Receives FDA 510(k) Clearance for HD-550 Endoscopy system

Third quarter 2021 earnings released: EPS CN¥0.076 (vs CN¥0.004 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.18 (vs CN¥0.085 in 2Q 2020)

SonoScape Obtains CE-Mark for Its Linear Array Echoendoscope EG-UC5T

Price target increased to CN¥30.86

Sonoscape Medical Corp. Proposes Final Cash Dividend for 2020

First quarter 2021 earnings released: EPS CN¥0.09 (vs CN¥0.02 loss in 1Q 2020)

New 90-day low: CN¥20.36

SonoScape Medical Corp. Announces Executive Election

New 90-day low: CN¥21.50

New 90-day low: CN¥25.16

Third quarter earnings released

SonoScape Medical Corp. announced that it expects to receive CNY 1.2 billion in funding

New 90-day low: CN¥27.25

Analysts lower EPS estimates to CN¥0.40

Earnings released

New 90-day low - CN¥30.72

SonoScape Medical Corp. to Report First Half, 2020 Results on Aug 26, 2020

CEO

테뉴어

보상